Influenza vaccines in low and middle income countries

References

• Nichol KL. Cost-effectiveness and socio-economic aspects of childhood influenza vaccination. Vaccine 2011; 29:7554 - 8; http://dx.doi.org/10.1016/j.vaccine.2011.08.015; PMID: 21820477
   PubMed Web of Science ®Google Scholar
• Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; 17:Suppl 1 S3 - 10; http://dx.doi.org/10.1016/S0264-410X(99)00099-7; PMID: 10471173
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Pandemic influenza A (H1N1) 2009 virus vaccine - conclusions and recommendations from the October 2009 meeting of the immunization Strategic Advisory Group of Experts. Wkly Epidemiol Rec 2009; 84:505 - 8; PMID: 19960623
   PubMedGoogle Scholar
• World Health Organization (WHO). Acute respiratory infections. Update September 2009. The A/2009 H1N1 influenza virus pandemic. Available from: http://www.who.int/vaccine_research/diseases/ari/en/index5.html. [Accessed October 8, 2012].
   Google Scholar
• World Health Organization. Vaccines against influenza WHO position paper—November 2012. Wkly Epidemiol Rec 2012; 47:461
   Google Scholar
• Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination coverage levels among persons aged > or = 65 years--United States, 1973-1993. MMWR Morb Mortal Wkly Rep 1995; 44:506 - 7, 513-5; PMID: 7596336
   PubMedGoogle Scholar
• World Health Organization (WHO). Statement from WHO global Advisory Committee on Vaccine Safety about the safety profile of pandemic influenza A (H1N1) 2009 vaccines. Available from: http://www.who.int/csr/resources/publications/swineflu/cp164_2009_1612_gacvs_h1n1_vaccine_safety.pdf. [Accessed September 20, 2012]
   Google Scholar
• Fedson DS, Hirota Y, Shin HK, Cambillard PE, Kiely J, Ambrosch F, et al. Influenza vaccination in 22 developed countries: an update to 1995. Vaccine 1997; 15:1506 - 11; http://dx.doi.org/10.1016/S0264-410X(97)00091-1; PMID: 9330460
   PubMedGoogle Scholar
• Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ. An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11. BMC Infect Dis 2011; 11:230; http://dx.doi.org/10.1186/1471-2334-11-230; PMID: 21871096
   PubMed Web of Science ®Google Scholar
• Cohen GM, Nettleman MD. Economic impact of influenza vaccination in preschool children. Pediatrics 2000; 106:973 - 6; http://dx.doi.org/10.1542/peds.106.5.973; PMID: 11061762
   PubMed Web of Science ®Google Scholar
• Luce BR, Zangwill KM, Palmer CS, Mendelman PM, Yan L, Wolff MC, et al. Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children. Pediatrics 2001; 108:E24; http://dx.doi.org/10.1542/peds.108.2.e24; PMID: 11483834
   PubMedGoogle Scholar
• Mullooly JP, Bennett MD, Hornbrook MC, Barker WH, Williams WW, Patriarca PA, et al. Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization. Ann Intern Med 1994; 121:947 - 52; http://dx.doi.org/10.7326/0003-4819-121-12-199412150-00008; PMID: 7978721
   PubMed Web of Science ®Google Scholar
• Nichol KL. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza. Arch Intern Med 2001; 161:749 - 59; http://dx.doi.org/10.1001/archinte.161.5.749; PMID: 11231710
   PubMed Web of Science ®Google Scholar
• Nichol KL, Mallon KP, Mendelman PM. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine. Vaccine 2003; 21:2207 - 17; http://dx.doi.org/10.1016/S0264-410X(03)00029-X; PMID: 12706712
   PubMed Web of Science ®Google Scholar
• Scuffham PA, West PA. Economic evaluation of strategies for the control and management of influenza in Europe. Vaccine 2002; 20:2562 - 78; http://dx.doi.org/10.1016/S0264-410X(02)00154-8; PMID: 12057614
   PubMed Web of Science ®Google Scholar
• Postma MJ, Baltussen RP, Palache AM, Wilschut JC. Further evidence for favorable cost-effectiveness of elderly influenza vaccination. Expert Rev Pharmacoecon Outcomes Res 2006; 6:215 - 27; http://dx.doi.org/10.1586/14737167.6.2.215; PMID: 20528557
   PubMedGoogle Scholar
• Scott WG, Scott HM. Economic evaluation of vaccination against influenza in New Zealand. Pharmacoeconomics 1996; 9:51 - 60; http://dx.doi.org/10.2165/00019053-199609010-00006; PMID: 10160087
   PubMed Web of Science ®Google Scholar
• Meltzer MI, Neuzil KM, Griffin MR, Fukuda K. An economic analysis of annual influenza vaccination of children. Vaccine 2005; 23:1004 - 14; http://dx.doi.org/10.1016/j.vaccine.2004.07.040; PMID: 15620473
   PubMed Web of Science ®Google Scholar
• Jit M, Cromer D, Baguelin M, Stowe J, Andrews N, Miller E. The cost-effectiveness of vaccinating pregnant women against seasonal influenza in England and Wales. Vaccine 2010; 29:115 - 22; http://dx.doi.org/10.1016/j.vaccine.2010.08.078; PMID: 21055501
   PubMed Web of Science ®Google Scholar
• Skedgel C, Langley JM, MacDonald NE, Scott J, McNeil S. An incremental economic evaluation of targeted and universal influenza vaccination in pregnant women. Can J Public Health 2011; 102:445 - 50; PMID: 22164556
   PubMed Web of Science ®Google Scholar
• Fitzner KA, Shortridge KF, McGhee SM, Hedley AJ. Cost-effectiveness study on influenza prevention in Hong Kong. Health Policy 2001; 56:215 - 34; http://dx.doi.org/10.1016/S0168-8510(00)00140-8; PMID: 11399347
   PubMed Web of Science ®Google Scholar
• Gatwood J, Meltzer MI, Messonnier M, Ortega-Sanchez IR, Balkrishnan R, Prosser LA. Seasonal influenza vaccination of healthy working-age adults: a review of economic evaluations. Drugs 2012; 72:35 - 48; http://dx.doi.org/10.2165/11597310-000000000-00000; PMID: 22191794
   PubMed Web of Science ®Google Scholar
• Myers ER, Misurski DA, Swamy GK. Influence of timing of seasonal influenza vaccination on effectiveness and cost-effectiveness in pregnancy. Am J Obstet Gynecol 2011; 204:Suppl 1 S128 - 40; http://dx.doi.org/10.1016/j.ajog.2011.04.009; PMID: 21640230
   PubMedGoogle Scholar
• Dayan GH, Nguyen VH, Debbag R, Gómez R, Wood SC. Cost-effectiveness of influenza vaccination in high-risk children in Argentina. Vaccine 2001; 19:4204 - 13; http://dx.doi.org/10.1016/S0264-410X(01)00160-8; PMID: 11457546
   PubMed Web of Science ®Google Scholar
• Available at epocoslo.cochrane.org/ lmic-databases, last update November 2010, accessed at May 5, 2011
   Google Scholar
• Walker DG, Hutubessy R, Beutels P. WHO Guide for standardisation of economic evaluations of immunization programmes. Vaccine 2010; 28:2356 - 9; http://dx.doi.org/10.1016/j.vaccine.2009.06.035; PMID: 19567247
   PubMed Web of Science ®Google Scholar
• Yoldascan E, Kurtaran B, Koyuncu M, Koyuncu E. Modeling the economic impact of pandemic influenza: a case study in Turkey. J Med Syst 2010; 34:139 - 45; http://dx.doi.org/10.1007/s10916-008-9225-x; PMID: 20433052
   PubMedGoogle Scholar
• Zubareva LA, Evdoshenko VG, Turovskaia SI, Krivchemko EI, Shall’ AIa. [Epidemiological and economic evaluation of the effectiveness of immunization with live influenza vaccine during the influenza epidemic of 1971-1973 in the city of Frunze]. Zdravookhr Kirg 1976; 3:21 - 4; PMID: 7895
   PubMedGoogle Scholar
• Xing LH, Ge CM, Xing LJ. Cost-benefit analysis of influenza vaccination in Rizhao City, Shangdong Province, China. Chin J Biol 2008; 21:692 - 4
   Google Scholar
• Nichol KL. Complications of influenza and benefits of vaccination. Vaccine 1999; 17:Suppl 1 S47 - 52; http://dx.doi.org/10.1016/S0264-410X(99)00105-X; PMID: 10471180
   PubMedGoogle Scholar
• Wang MC, Wang TP, Yang SM. [Effectiveness of 23-valent penumococcal polysaccharide and split-virus influenza vaccines to prevent respiratory diseases for elderly people]. Zhongguo Yi Miao He Mian Yi 2010; 16:229 - 32; PMID: 20726264
   PubMedGoogle Scholar
• Apisarnthanarak A, Puthavathana P, Kitphati R, Auewarakul P, Mundy LM. Outbreaks of influenza A among nonvaccinated healthcare workers: implications for resource-limited settings. Infect Control Hosp Epidemiol 2008; 29:777 - 80; http://dx.doi.org/10.1086/588162; PMID: 18624648
   PubMedGoogle Scholar
• Wood SC, Alexseiv A, Nguyen VH. Effectiveness and economical impact of vaccination against influenza among a working population in Moscow. Vaccine 1999; 17:Suppl 3 S81 - 7; http://dx.doi.org/10.1016/S0264-410X(99)00299-6; PMID: 10559541
   PubMed Web of Science ®Google Scholar
• Ivannikov IuG, Efimenko IB, Marinich IG, Luk’ianov IuV, Naĭkhin AN. [Evaluation of mass influenza prevention effectiveness using an inactivated chromatographic vaccine in Leningrad]. Zh Mikrobiol Epidemiol Immunobiol 1980; 11:18 - 27; PMID: 6449811
   PubMedGoogle Scholar
• Sharipova IS, Kuz’minykh SI, Fel’dblium IV. [An evaluation of the epidemiological and economic efficacy of immunizing adults with the Vaxigrippe vaccine]. Zh Mikrobiol Epidemiol Immunobiol 1998; 4:46 - 9; PMID: 9783400
   PubMedGoogle Scholar
• At’kov OY, Azarov AV, Zhukov DA, Nicoloyannis N, Durand L. Influenza vaccination in healthy working adults in Russia: observational study of effectiveness and return on investment for the employer. Appl Health Econ Health Policy 2011; 9:89 - 99; http://dx.doi.org/10.2165/11538680-000000000-00000; PMID: 21332253
   PubMedGoogle Scholar
• Burckel E, Ashraf T, de Sousa Filho JP, Forleo Neto E, Guarino H, Yauti C, et al. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company. Pharmacoeconomics 1999; 16:563 - 76; http://dx.doi.org/10.2165/00019053-199916050-00012; PMID: 10662481
   PubMed Web of Science ®Google Scholar
• Morales A, Martinez MM, Tasset-Tisseau A, Rey E, Baron-Papillon F, Follet A. Costs and benefits of influenza vaccination and work productivity in a Colombian company from the employer’s perspective. Value Health 2004; 7:433 - 41; http://dx.doi.org/10.1111/j.1524-4733.2004.74006.x; PMID: 15449635
   PubMed Web of Science ®Google Scholar
• Samad AH, Usul MH, Zakaria D, Ismail R, Tasset-Tisseau A, Baron-Papillon F, et al. Workplace vaccination against influenza in Malaysia: does the employer benefit?. J Occup Health 2006; 48:1 - 10; http://dx.doi.org/10.1539/joh.48.1; PMID: 16484757
   PubMedGoogle Scholar
• Aballéa S, Chancellor J, Martin M, Wutzler P, Carrat F, Gasparini R, et al. The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health 2007; 10:98 - 116; http://dx.doi.org/10.1111/j.1524-4733.2006.00157.x; PMID: 17391419
   PubMed Web of Science ®Google Scholar
• Chicaíza-Becerra LA, García-Molina M, Ballesteros M, Gamboa O, Díaz J, Vega R. [Economic evaluation of influenza vaccine applied to health personnel attending hospitalised oncological patients]. Rev Salud Publica (Bogota) 2008; 10:756 - 66; PMID: 19360224
   PubMedGoogle Scholar
• Porras-Ramírez A, Alvis-Guzmán N, Rico-Mendoza A, Alvis-Estrada L, Castañeda-Orjuela CA, Velandia-González MP, et al. [Cost effectiveness of influenza vaccination in children under 2 years old and elderly in Colombia]. Rev Salud Publica (Bogota) 2009; 11:689 - 99; PMID: 20339595
   PubMedGoogle Scholar
• Gutiérrez JP, Bertozzi SM. [Influenza vaccination in the elderly population in Mexico: economic considerations]. Salud Publica Mex 2005; 47:234 - 9; PMID: 16104466
   PubMed Web of Science ®Google Scholar
• Praditsuwan R, Assantachai P, Wasi C, Puthavatana P, Kositanont U. The efficacy and effectiveness of influenza vaccination among Thai elderly persons living in the community. J Med Assoc Thai 2005; 88:256 - 64; PMID: 15962680
   PubMedGoogle Scholar
• Wongsurakiat P, Lertakyamanee J, Maranetra KN, Jongriratanakul S, Sangkaew S. Economic evaluation of influenza vaccination in Thai chronic obstructive pulmonary disease patients. J Med Assoc Thai 2003; 86:497 - 508; PMID: 12924797
   PubMedGoogle Scholar
• Gao JM, Yu Q, Tang GH. [Cost-benefit analysis on the strategy of social health insurance regarding vaccination against influenza in Xi’an city]. Zhonghua Liu Xing Bing Xue Za Zhi 2008; 29:17 - 22; PMID: 18785471
   PubMedGoogle Scholar
• Liu M, Liu GF, Wang Y, Zhao W, Wang L, Shi W, et al. [Study on the effectiveness and cost-benefit of influenza vaccine on elderly population in Beijing city]. Zhonghua Liu Xing Bing Xue Za Zhi 2005; 26:412 - 6; PMID: 16185449
   PubMedGoogle Scholar
• Palache B. New vaccine approaches for seasonal and pandemic influenza. Vaccine 2008; 26:6232 - 6; http://dx.doi.org/10.1016/j.vaccine.2008.07.022; PMID: 18674583
   PubMedGoogle Scholar
• Deogaonkar R, Hutubessy R, van der Putten I, Evers S, Jit M. Systematic review of studies evaluating the broader economic impact of vaccination in low and middle income countries. BMC Public Health 2012; 12:878; http://dx.doi.org/10.1186/1471-2458-12-878; PMID: 23072714
   PubMed Web of Science ®Google Scholar